EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Network Pharmacology, Molecular Docking, and Experimental Validation: Andrographolide Attenuates Acute Liver Injury via the NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Pathway

Yankun Zhang, Shuanghui Liu, Xiaoxia Liang, Lizi Yin iD, Changliang He iD

Biomolecules · 2025

DOI: 10.3390/biom15121743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Yankun Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Veterinary, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China. Hauptthemen laut MEDLINE: Diterpenes, Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Caspase 1. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Andrographolide (Andro), a natural diterpenoid lactone, possesses a wide range of pharmacological properties, including notable anti-inflammatory, antioxidant, antitumor, and immunomodulatory activities. Despite its acknowledged therapeutic promise, the exact protective mechanisms underlying its efficacy against acute liver injury (ALI) are still not fully understood. Consequently, determining the molecular mechanisms through which andrographolide alleviates ALI is of substantial scientific and clinical relevance.

Methods

Andrographolide’s potential targets and pharmacological mechanisms against liver injury were initially identified using network pharmacology and molecular docking. An acute liver injury (ALI) rat model was induced by intraperitoneal injection of lipopolysaccharide (LPS). The therapeutic efficacy of andrographolide in ALI was evaluated by examining liver histopathology, measuring liver function and oxidative stress markers, and quantifying pro-inflammatory cytokine levels. Meanwhile, the expression of key constituents along the NLRP3/caspase-1/GSDMD signaling axis was quantified using RT-qPCR and Western blotting. In parallel, the protective effect of andrographolide via the canonical NLRP3/caspase-1/GSDMD pyroptosis pathway was further examined in vitro using LPS-plus-ATP-stimulated rat hepatocyte BRL-3A cells.

Results

Network pharmacology analysis predicted that andrographolide (Andro) protects against liver injury mainly by targeting core regulators of pyroptosis. Molecular docking simulations further indicated stable binding interactions between Andro and key proteins involved in the pyroptotic pathway, such as NLRP3, ASC, GSDMD, and CASP1. These predictions were experimentally confirmed. Andro administration notably mitigated histopathological alterations, restored serum liver function indicators, lowered pro-inflammatory cytokine levels, and alleviated oxidative stress. Importantly, Andro substantially suppressed the expression of critical mediators along the pyroptosis signaling cascade.

Conclusions

This study demonstrates that andrographolide (Andro) ameliorates acute liver injury (ALI) by specifically inhibiting the NLRP3/Caspase-1/GSDMD-mediated pyroptosis pathway. By elucidating this underlying molecular mechanism, our work highlights Andro’s potential as a novel and promising therapeutic candidate for ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiterpenesPyroptosisNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Intracellular Signaling Peptides and ProteinsAnimalsMolecular Docking SimulationRatsMaleNetwork PharmacologySignal TransductionLipopolysaccharidesRats, Sprague-DawleyChemical and Drug Induced Liver InjuryLiverOxidative StressGasderminsPhosphate-Binding Proteins

Stichwörter der Autor:innen

acute liver injuryandrographolidemolecular dockingnetwork pharmacologypyroptosis

Substanzen

DiterpenesandrographolideNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Gsdmd protein, ratNlrp3 protein, ratLipopolysaccharidesIntracellular Signaling Peptides and ProteinsGasderminsPhosphate-Binding Proteins

Autor:innen und Institutionen

  • Department of Clinical Veterinary, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China.
  • Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China.
  • Department of Pharmacy, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China.

ORCID-Profile: Lizi Yin, Changliang He

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Zhang, Y., Liu, S., Liang, X., Yin, L., & He, C. (2025). Integrating Network Pharmacology, Molecular Docking, and Experimental Validation: Andrographolide Attenuates Acute Liver Injury via the NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Pathway. Biomolecules. https://doi.org/10.3390/biom15121743

Vancouver

Zhang Y, Liu S, Liang X, Yin L, He C. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation: Andrographolide Attenuates Acute Liver Injury via the NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Pathway. Biomolecules. 2025. doi:10.3390/biom15121743

BibTeX
@article{Zhang2025,
  author = {Zhang, Yankun and Liu, Shuanghui and Liang, Xiaoxia and Yin, Lizi and He, Changliang},
  title = {Integrating Network Pharmacology, Molecular Docking, and Experimental Validation: Andrographolide Attenuates Acute Liver Injury via the NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Pathway},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15121743}
}
Kostenlos starten →